Refractory colorectal adenocarcinoma
Clinical trials for Refractory colorectal adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Refractory colorectal adenocarcinoma trials appear
Sign up with your email to follow new studies for Refractory colorectal adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough colorectal cancer: experimental drug combo enters human testing
Disease control Recruiting nowThis early-phase trial is testing whether adding an experimental drug called ZEN003694 to two approved cancer drugs (cetuximab and encorafenib) can help patients with a specific type of advanced colorectal cancer that has not responded to prior treatments. The study involves 30 a…
Matched conditions: REFRACTORY COLORECTAL ADENOCARCINOMA
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Experimental combo aims to tackle stubborn colorectal cancer
Disease control Recruiting nowThis trial is testing whether combining pidnarulex (a drug that blocks cancer cell growth) with cemiplimab (an immunotherapy that helps the immune system attack cancer) is safe and effective for people with advanced colorectal cancer that no longer responds to standard treatments…
Matched conditions: REFRACTORY COLORECTAL ADENOCARCINOMA
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC